Your browser doesn't support javascript.
loading
MacroH2A histone variants modulate enhancer activity to repress oncogenic programs and cellular reprogramming.
Mohammed Ismail, Wazim; Mazzone, Amelia; Ghiraldini, Flavia G; Kaur, Jagneet; Bains, Manvir; Munankarmy, Amik; Bagwell, Monique S; Safgren, Stephanie L; Moore-Weiss, John; Buciuc, Marina; Shimp, Lynzie; Leach, Kelsey A; Duarte, Luis F; Nagi, Chandandeep S; Carcamo, Saul; Chung, Chi-Yeh; Hasson, Dan; Dadgar, Neda; Zhong, Jian; Lee, Jeong-Heon; Couch, Fergus J; Revzin, Alexander; Ordog, Tamas; Bernstein, Emily; Gaspar-Maia, Alexandre.
  • Mohammed Ismail W; Division of Experimental Pathology, Department of Lab Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Mazzone A; Center for Individualized Medicine, Epigenomics program, Mayo Clinic, Rochester, MN, USA.
  • Ghiraldini FG; Division of Experimental Pathology, Department of Lab Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Kaur J; Center for Individualized Medicine, Epigenomics program, Mayo Clinic, Rochester, MN, USA.
  • Bains M; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Munankarmy A; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Bagwell MS; Division of Experimental Pathology, Department of Lab Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Safgren SL; Center for Individualized Medicine, Epigenomics program, Mayo Clinic, Rochester, MN, USA.
  • Moore-Weiss J; Division of Experimental Pathology, Department of Lab Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Buciuc M; Center for Individualized Medicine, Epigenomics program, Mayo Clinic, Rochester, MN, USA.
  • Shimp L; Division of Experimental Pathology, Department of Lab Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Leach KA; Center for Individualized Medicine, Epigenomics program, Mayo Clinic, Rochester, MN, USA.
  • Duarte LF; Division of Experimental Pathology, Department of Lab Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Nagi CS; Center for Individualized Medicine, Epigenomics program, Mayo Clinic, Rochester, MN, USA.
  • Carcamo S; Division of Experimental Pathology, Department of Lab Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Chung CY; Center for Individualized Medicine, Epigenomics program, Mayo Clinic, Rochester, MN, USA.
  • Hasson D; Division of Experimental Pathology, Department of Lab Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Dadgar N; Center for Individualized Medicine, Epigenomics program, Mayo Clinic, Rochester, MN, USA.
  • Zhong J; Division of Experimental Pathology, Department of Lab Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Lee JH; Center for Individualized Medicine, Epigenomics program, Mayo Clinic, Rochester, MN, USA.
  • Couch FJ; Division of Experimental Pathology, Department of Lab Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Revzin A; Center for Individualized Medicine, Epigenomics program, Mayo Clinic, Rochester, MN, USA.
  • Ordog T; Division of Experimental Pathology, Department of Lab Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Bernstein E; Center for Individualized Medicine, Epigenomics program, Mayo Clinic, Rochester, MN, USA.
  • Gaspar-Maia A; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Commun Biol ; 6(1): 215, 2023 02 23.
Article en En | MEDLINE | ID: mdl-36823213
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Factores de Transcripción / Proteínas Nucleares Límite: Animals Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Factores de Transcripción / Proteínas Nucleares Límite: Animals Idioma: En Año: 2023 Tipo del documento: Article